Clin Lab: Blood tests have identified COVID-19-end biomarkers

8, 2020 // -- Researchers at the Seville Institute for Biomedical Research (IBIS) presented a study conducted in the Clinical Biochemistry Service at The University Hospital of Virgin del Rocio, which identified six biomarkers indicating that patients may have been infected with SARS-CoV-2.
(Photo: www.pixabay.com) The key novelty of the study, led by Dr. Juan Miguel Guerrero, head of services and IR at the IBiS Molecular Neuroimmune Endocrinology Group, is that the study was conducted using blood tests and can be determined in about 60 minutes.
clinical biochemistry service assessed routine blood tests on more than 200 people in emergency rooms to detect infection.
specifically, they analyzed the accuracy of each biomarker to distinguish between patients infected with COVID-19 and those who were not infected with COVID-19.
Researchers in this study used blood lymphocytes and eosinophil counts, as well as the content of ferrine, lactic acid dehydrogenase, C-reactive protein and d-d-polymers in plasma, to establish six criteria associated with suspected COVID-19 infections.
91% of patients infected with COVID-19 met one or more of these biomarker standards.
, it is possible to rule out coronavirus infection with a high probability in patients who do not meet these criteria.
in the study, researchers worked with Blueberry Diagnostics to create an algorithm that uses artificial intelligence to identify patients infected with COVID-19 with 100% sensitivity and 100% specificity.
has developed a second algorithm that can detect patients with more severe prognostic prognostication, prioritization of treatment and reduced mortality.
() Source: Identifying Markers of COVID-19 covid-19 using blood tests Source: Jose Santotoribio et al. Evaluation of Routine Blood Tests for Diagnosis of Suspected Coronavirus Disease 2019, Clinical Laboratory (2020). DOI: 10.7754/Clin.Lab.2020.200522。